Metraipolis › archive › dc_f088fa8a5ea5

CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons — Europe PMC PMID:42327587

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42327587
DOI: 10.7150/jca.136122
License (as archived): solo-consultazione
Archived: 2026-11-01T07:41:31.417Z
SHA-256 of the archived text: a02ab000a17182f90e674c3cd17fa91815e3919f31ba018862214136f545d9fb
Stable URL of this page: https://metraipolis.com/documento/dc_f088fa8a5ea5

How to cite

CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons — Europe PMC PMID:42327587 — Europe PMC (en), https://europepmc.org/article/MED/42327587 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f088fa8a5ea5 (Metraipolis archive dc_f088fa8a5ea5, sha256 a02ab000a17182f90e674c3cd17fa91815e3919f31ba018862214136f545d9fb)

BibTeX

@misc{dcf088fa8a5ea5,
  title = {CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons — Europe PMC PMID:42327587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42327587},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f088fa8a5ea5; sha256 a02ab000a17182f90e674c3cd17fa91815e3919f31ba018862214136f545d9fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42327587. Agents can read the archived copy with the MCP tool read_document.